Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Deere & Company (DE) vs McKesson Corporation (MCK) Price & Performance

Deere & CompanyTrade
McKesson CorporationTrade

Price performance (Past 24H)

Key statistics

Deere & Company vs McKesson Corporation — how do they compare? Deere & Company trades at $584.4 (market cap $158.09B), while McKesson Corporation trades at $801.49 (market cap $95.10B). The key difference: Deere & Company is the larger of the two by market cap, and Deere & Company pays the higher dividend (1.11%). Which is the better fit depends on your goals.

DEMCK
Market Cap
$158.09B$95.10B
Sector
IndustrialsHealth
52-Week High
$662.49$995.69
52-Week Low
$439.11$659.01
Enterprise Value
$212.91B$99.74B
Dividend Yield
1.11%0.4%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Deere & Company

Deere & Company (DE) trades at $585.64, down 0.21% on the day, with a bearish technical signal from moving averages and oscillators. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 results pending. Revenue declined to $44.67B in 2025, though net income margin remains solid at 10.33%. Recent news highlights a $20B precision agriculture initiative and regulatory agreements enhancing farmer access to repair tools.

The outlook is mixed: analyst consensus targets $676.08 (15% upside) with 41% buy ratings, but technicals and declining revenue pose near-term risks. Key opportunities include margin strength and agtech growth; risks involve cyclical farming demand and high debt levels. Investors should weigh fundamental resilience against sector headwinds.

McKesson Corporation

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Deere & Company

Deere is the world's leading manufacturer of agricultural equipment, producing some of the most recognizable machines in the heavy machinery industry. The company is divided into four reportable segments: production and precision agriculture, small agriculture and turf, construction and forestry, and John Deere Capital. Its products are available through an extensive dealer network, which includes over 1,900 dealer locations in North America and approximately 3,700 locations globally. John Deere Capital provides retail financing for machinery to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Deere product sales.

Read more on DE

About McKesson Corporation

McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Read more on MCK